Achillion Pharmaceuticals
ACHN
ACHN was delisted on the 27th of January, 2020.
152 hedge funds and large institutions have $1.24B invested in Achillion Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 47 increasing their positions, 49 reducing their positions, and 18 closing their positions.
143% more call options, than puts
Call options by funds: $41.9M | Put options by funds: $17.2M
72% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 18
50% more capital invested
Capital invested by funds: $829M → $1.24B (+$415M)
8% more funds holding
Funds holding: 141 → 152 (+11)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
4% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 49
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$41.3M |
| 2 |
O
OrbiMed
New York
|
+$40.2M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$10.1M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.45M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$6.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$69.5M |
| 2 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$14.1M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$8.18M |
| 4 |
State Street
Boston,
Massachusetts
|
-$7.79M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.32M |
ACHN Hedge Fund Activity: Q4 2015 in Review
152 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Achillion Pharmaceuticals (ACHN) for Q4 2015, worth a combined $1.24B — up 50% from $829M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new ACHN positions and 18 closed out — a net gain of 13 holders — while 47 added to existing stakes and 49 trimmed.
The largest buyer was Millennium Management, adding an estimated $41.3M. The largest seller was Wellington Management Group, cutting an estimated $69.5M.
- 152 institutional investors held Achillion Pharmaceuticals (ACHN) as of Q4 2015, up from 141 in Q3 2015.
- Funds reported $1.24B of Achillion Pharmaceuticals stock for Q4 2015, up 50% quarter-over-quarter.
- 31 funds opened new Achillion Pharmaceuticals positions in Q4 2015 and 18 closed out, a net change of +13 holders.
- The largest Achillion Pharmaceuticals buyer in Q4 2015 was Millennium Management, an estimated $41.3M added.
- The largest Achillion Pharmaceuticals seller in Q4 2015 was Wellington Management Group, an estimated $69.5M sold.
Based on aggregated 13F filings for Q4 2015.